​

Disc Medicine (IRON) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

IRON Stock Forecast

Disc Medicine (IRON) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $90.33, with a high of $112.00 and a low of $70.00. This represents a 120.32% increase from the last price of $41.00.

$25 $43 $61 $79 $97 $115 High: $112 Avg: $90.33 Low: $70 Last Closed Price: $41

IRON Stock Rating

Disc Medicine stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 7 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 7 Strong Sell Sell Hold Buy Strong Buy

IRON Price Target Upside V Benchmarks

TypeNameUpside
StockDisc Medicine120.32%
SectorHealthcare Stocks 33.91%
IndustryBiotech Stocks 83.49%

Price Target Trends

1M3M12M
# Anlaysts--8
Avg Price Target--$72.38
Last Closing Price$41.00$41.00$41.00
Upside/Downside--76.54%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 2548---12
Mar, 2548---12
Feb, 2547---11
Jan, 2547---11
Dec, 2448---12
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 05, 2024Greg HarrisonScotiabank$70.00$64.788.06%70.73%
Nov 05, 2024Evan David SeigermanBMO Capital$112.00$63.2477.10%173.17%
Oct 23, 2024Roger SongJefferies$89.00$50.9274.78%117.07%
Sep 16, 2024Douglas TsaoH.C. Wainwright$70.00$47.7946.47%70.73%
Aug 22, 2024Tiago FauthWells Fargo$75.00$49.3152.10%82.93%
Aug 08, 2024Danielle BrillRaymond James$50.00$42.8516.69%21.95%
Jun 17, 2024Evan David SeigermanBMO Capital$70.00$45.8052.84%70.73%
May 10, 2024Danielle BrillRaymond James$43.00$29.9543.57%4.88%
Apr 02, 2024Evan David SeigermanBMO Capital$50.00$34.2146.16%21.95%
Apr 01, 2024Ben BurnettStifel Nicolaus$71.00$34.21107.54%73.17%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 18, 2025Cantor FitzgeraldOverweightOverweighthold
Nov 05, 2024ScotiabankSector OutperformSector Outperformhold
Oct 23, 2024JefferiesBuyinitialise
Oct 16, 2024ScotiabankOutperforminitialise
Sep 16, 2024H.C. WainwrightBuyBuyhold
Aug 22, 2024Wells FargoOverweightinitialise
Aug 08, 2024Raymond JamesOutperformOutperformhold
Jun 14, 2024WedbushOutperformOutperformhold
Jun 13, 2024BMO CapitalOutperformOutperformhold
May 10, 2024Raymond JamesOutperformOutperformhold

Financial Forecast

EPS Forecast

$-10 $-7 $-4 $-1 $2 $5 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-3.43-----
Avg Forecast$-3.25$-4.13$-5.21$-5.35$-4.12$-0.32
High Forecast$-2.96$-3.94$-4.20$-3.89$2.49$-0.32
Low Forecast$-3.58$-4.50$-6.08$-8.11$-8.83$-0.32
Surprise %5.54%-----

Revenue Forecast

$0 $70M $140M $210M $280M $350M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast--$6.06M$38.61M$117.86M$308.23M
High Forecast--$6.07M$38.61M$117.86M$308.23M
Low Forecast--$6.04M$38.61M$117.86M$308.23M
Surprise %------

Net Income Forecast

$-200M $-140M $-80M $-20M $40M $100M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-76.43M-----
Avg Forecast$-76.43M$-94.10M$-114.74M$-178.09M$-145.87M$-7.04M
High Forecast$-66.05M$-87.87M$-93.71M$-86.87M$55.55M$-7.04M
Low Forecast$-79.93M$-100.32M$-135.76M$-181.01M$-197.16M$-7.04M
Surprise %------

IRON Forecast FAQ

Is Disc Medicine stock a buy?

Disc Medicine stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 7 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Disc Medicine is a favorable investment for most analysts.

What is Disc Medicine's price target?

Disc Medicine's price target, set by 7 Wall Street analysts, averages $90.33 over the next 12 months. The price target range spans from $70 at the low end to $112 at the high end, suggesting a potential 120.32% change from the previous closing price of $41.

How does Disc Medicine stock forecast compare to its benchmarks?

Disc Medicine's stock forecast shows a 120.32% upside, outperforming the average forecast for the healthcare stocks sector (33.91%) and outperforming the biotech stocks industry (83.49%).

What is the breakdown of analyst ratings for Disc Medicine over the past three months?

  • April 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 36.36% Strong Buy, 63.64% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Disc Medicine’s EPS forecast?

Disc Medicine's average annual EPS forecast for its fiscal year ending in December 2024 is $-4.13, marking a 20.41% increase from the reported $-3.43 in 2023. Estimates for the following years are $-5.21 in 2025, $-5.35 in 2026, $-4.12 in 2027, and $-0.32 in 2028.

What is Disc Medicine’s revenue forecast?

Disc Medicine's average annual revenue forecast for its fiscal year ending in December 2024 is $0, reflecting a 0% decrease from the reported $0 in 2023. The forecast for 2025 is $6.06M, followed by $38.61M for 2026, $117.86M for 2027, and $308.23M for 2028.

What is Disc Medicine’s net income forecast?

Disc Medicine's net income forecast for the fiscal year ending in December 2024 stands at $-94.095M, representing an 23.11% increase from the reported $-76.429M in 2023. Projections indicate $-115M in 2025, $-178M in 2026, $-146M in 2027, and $-7.041M in 2028.